Table 3. Cox Proportional Hazards Regression Analysis of the Association of Local and Systemic Recurrence With Patient and Surgical Factorsa.
Characteristic | Hazard ratio (95% CI) | ||
---|---|---|---|
Local recurrence, univariate | Systemic recurrence | ||
Univariate | Multivariate | ||
Body mass index | |||
Underweight or normal | 1 [Reference] | 1 [Reference] | NA |
Overweight | 0.96 (0.38-2.45) | 0.99 (0.48-2.04) | NA |
Obese | 0.41 (0.09-1.86) | 0.59 (0.33-1.05) | NA |
Sex | |||
Female | 1 [Reference] | 1 [Reference] | NA |
Male | 1.62 (0.85-3.07) | 0.94 (0.59-1.47) | NA |
Neoadjuvant therapy | |||
No | 1 [Reference] | 1 [Reference] | 1 [Reference] |
Yes | 0.75 (0.31-1.83) | 1.99 (1.27-3.13)b | 1.70 (0.90-3.21) |
AJCC stage (clinical) | |||
I | 1 [Reference] | 1 [Reference] | 1 [Reference] |
II | 0.60 (0.36-1.01) | 1.35 (0.73-2.49) | 0.72 (0.34-1.55) |
III | 1.42 (0.83-2.44) | 2.30 (1.31-4.03)b | 1.17 (0.46-2.98) |
IV | 1.26 (0.14-10.99) | NAc | NA |
Tumor height | 0.92 (0.76-1.12) | 1.03 (0.93-1.14) | NA |
Quality of mesorectum | |||
Incomplete | 1 [Reference] | 1 [Reference] | NA |
Complete | 0.63 (0.08-5.06) | 0.49 (0.13-1.76) | NA |
CRM | |||
Negative | 1 [Reference] | 1 [Reference] | 1 [Reference] |
Positive | 4.19 (2.86-6.15)b | 4.00 (2.22-7.19)b | 2.95 (1.26-6.91)b |
DRM | |||
Negative | 1 [Reference] | 1 [Reference] | 1 [Reference] |
Positive | NAd | 4.88 (1.55-15.33) | 3.37 (0.72-15.74) |
Abbreviations: AJCC, American Joint Committee on Cancer; CRM, circumferential radial margin; DRM, distal resection margin; NA, not applicable.
Both models were clustered by site, and the multivariable model was adjusted for neoadjuvant therapy, stage, CRM, and DRM.
Significant association.
Patients with disease stage IV were removed before data were analyzed.
A reliable estimate could not be derived owing to a lack of cases.